• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
SNT
Click for more information
0.00% 1.8¢

SYNTARA LIMITED

Market Cap $20.29M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

Syntara Limited, formerly Pharmaxis Ltd, is an Australia-based clinical-stage drug... Syntara Limited, formerly Pharmaxis Ltd, is an Australia-based clinical-stage drug development company with a focus on blood-related cancers. The Company’s highly productive drug discovery engine is driven by its expertise in amine oxidase inhibitors. Its lead candidate, PXS-5505, is used for the bone marrow cancer myelofibrosis, which causes a build-up of scar tissue that leads to loss of red and white blood cells and platelets. The Company is also advancing both oral and topical pan-LOX inhibitors in scar prevention and scar modification programs. Its PXS-4728 is a SSAO/MAOB inhibitor to treat sleep disorders and slow progression of neurodegenerative diseases like Parkinson’s by reducing neuroinflammation. The Company’s other drug candidates target fibrotic and inflammatory diseases such as kidney fibrosis, NASH, pulmonary fibrosis, and cardiac fibrosis. It has developed two respiratory products: Bronchitol, for cystic fibrosis, and Aridol, a lung function test.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
SNT
Ann: Quarterly Activities Report 		10/05/24 13 3.0K
10/05/24 Last post  ContangoPhil Comments Created with Sketch.  13  Views Created with Sketch.  3.0K 
SNT
Ann: Application for quotation of securities - SNT 		30/04/24 0 109
30/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  109 
SNT
Ann: Updated company investor presentation 		30/04/24 0 155
Metals & Mining SECTOR NEWS

Is IPO mania back for the ASX? Sun Silver jumps 100% on first day of listing

Read More   right-arrow Created with Sketch.
SS1
15 May 2024
SUN SILVER LIMITED
30/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  155 
SNT
Ann: Presentation for quarterly shareholder briefing 		30/04/24 0 99
30/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  99 
SNT
Ann: Quarterly Activities/Appendix 4C Cash Flow Report 		30/04/24 0 142
30/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  142 
SNT
Ann: Notification of cessation of securities - SNT 		29/04/24 0 139
29/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  139 
SNT
Ann: Phase 2 Trial Reaches 50% Recruitment 		28/04/24 13 3.4K
28/04/24 Last post  ContangoPhil Comments Created with Sketch.  13  Views Created with Sketch.  3.4K 
SNT
Ann: SNT Quarterly Report and Investor Briefing 		24/04/24 0 195
24/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  195 

See All Discussions arrow Created with Sketch.

Timeline

Application for quotation of securities - SNT
30 Apr 14:54
 
Updated company investor presentation
30 Apr 11:36
 
Presentation for quarterly shareholder briefing
30 Apr 10:38
 
Quarterly Activities Report
30 Apr 08:45
 
Quarterly Activities/Appendix 4C Cash Flow Report
30 Apr 08:44
 
Notification of cessation of securities - SNT
29 Apr 17:22
 
View More arrow Created with Sketch.

Featured News

SBW Retail Revolution: Shekel Brainweigh leads the charge in Digital Inventory Management
right-arrow Created with Sketch.
BGD Barton kicks off drilling on-site historical Tarcoola gold play
right-arrow Created with Sketch.
NEWS Meet Sun Silver – ASX's newest silver-gold player based in Nevada, USA
right-arrow Created with Sketch.
RDN Raiden inches closer to Andover South drilling as heritage report clears land
right-arrow Created with Sketch.
CCO Calmer Co clocks $150K in sales of its kava-based health drinks at Coles
right-arrow Created with Sketch.
MGU Magnum to raise US$210M to advance Saudi green pig iron plant
right-arrow Created with Sketch.
(20min delay)
Last
1.8¢ 		Change
0.000(0.00%) 		Mkt cap ! $20.29M
Open High Low Value Volume
1.8¢ 1.8¢ 1.7¢ $7.351K 408.9K

Buyers (Bids)

No. Vol. Price($)
3 850706 1.7¢
 

Sellers (Offers)

Price($) Vol. No.
1.8¢ 795780 4
View Market Depth
Last trade - 16.10pm 15/05/2024 (20 minute delay) ?
Last
1.7¢ 		  Change
0.000 ( 5.56 %)
Open High Low Volume
1.8¢ 1.8¢ 1.7¢ 182209
Last updated 14.45pm 15/05/2024 ?
SNT (ASX) Chart

Top Stories

Market Update: Materials and health push ASX up

The ASX200 is up nearly 0.6 of a percent, in line with futures’ predictions.Materials and healthcare are in the lead this morning @ both sectors are up more than a percent. Energy and industrials are a drag mid-session.In other news this morning @ the Wage Price Index (WPI) rose 0...
Is IPO mania back for the ASX? Sun Silver jumps 100% on first day of listing Sun Silver is enjoying a strong debut on the local bourse with shares up 100% to 40cps as miners enjoy budgetary stimulus.
Want copper with that? Boss Energy hits orange metal on-site uranium play The exploration team at Boss Energy announced on Wednesday that its latest drill run on-site has successfully found copper.
Retail Revolution: Shekel Brainweigh leads the charge in Digital Inventory Management Industry specialist Shekel Brainweigh (ASX:SBW) has built AI into its high-tech product scale and weighing technologies.
Recce Pharma heading closer to full efficacy data for flagship R327 Recce Pharma has announced the latest cohort of patients in the company's Phase I/II UTI trial has been dosed.

Featured News

MGU Magnum to raise US$210M to advance Saudi green pig iron plant
right-arrow Created with Sketch.
BPH BPH Energy reveals high-profile firms included in latest $1M placement
right-arrow Created with Sketch.
NEWS Meet Sun Silver – ASX's newest silver-gold player based in Nevada, USA
right-arrow Created with Sketch.
BGD Barton kicks off drilling on-site historical Tarcoola gold play
right-arrow Created with Sketch.
RDN Raiden inches closer to Andover South drilling as heritage report clears land
right-arrow Created with Sketch.
RCE Recce Pharma heading closer to full efficacy data for flagship R327
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.